Mishima, Eikan http://orcid.org/0000-0002-3706-2745
Wahida, Adam
Seibt, Tobias
Conrad, Marcus http://orcid.org/0000-0003-1140-5612
Article History
Received: 16 January 2023
Accepted: 12 May 2023
First Online: 19 June 2023
Competing interests
: E.M. has filed a patent related to the treatment of ferroptosis-associated diseases with vitamin K (WO2022075444A1). M.C. is a cofounder and shareholder of ROSCUE Therapeutics, which is developing ferroptosis inhibitors. The other authors declare no competing interests.